Drugs Made In America Acquisition Corp. Units (DMAAU) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 217.86M |
| Enterprise Value | 217.85M |
| P/E Ratio | 52 |
| PEG Ratio | -0.52 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.04 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -136.52 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | 0.03 |
| Return On Equity | 0.03 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -2.82M |
| Net Income | 5.94M |
| Diluted EPS | 0.19 |
| Total Cash | 14,887 |
| Total Cash/Share | 0 |
| Total Debt | 100,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 0.03 |
| Book Value Per Share | 10.2 |
| 52-Week Change | 5.77 |
| 52-Week High | 12.5 |
| 52-Week Low | 10.3 |
| Moving Average 50 Days | 10.76 |
| Moving Average 200 Days | 10.57 |
| Average Volume | 670 |
| Shares Outstanding | 23.43M |
| % Held by Institutions | 0.05 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |